Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.

Also called NCT04595968

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 267 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04595968
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Ireland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04595968. Randomized; triple masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2024-08-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
Intervention (Device)
Vestal DM Active device
Intervention (Behavioral)
Lifestyle modification
Intervention (Device)
Vestal DM Sham device
Lead sponsor
Neurovalens Ltd. (class: industry)
Collaborator
University College Dublin (class: other)
Collaborator
CS Lifescience (class: not stated)
Collaborator
Clinical Trial Mentors (class: industry)

Record details

Record id
cardio:ct-nct04595968
Content hash
2410735336708cfce1472713a93cf94b0257254f198b4d75fa14889ae823387f